About Doctor
Dr. Lee Je-hwan is among the best doctor for treatment of leukemia and blood related disorders in Seoul, South Korea.
- Dr. Lee Je-hwan education
-
- Doctor of Medicine : Chungbuk National University
- Master of Medicine : University of Ulsan
- Bachelor of Medicine : Seoul National University
- Dr. Lee Je-hwan major professional experiences
-
- Professor in Hematology, UUCM AMC
- Associate Professor in Hematology, UUCM AMC
- Assistant Professor in HematoOncology, UUCM AMC
- Clinical Instructor in HematoOncology, UUCM AMC
- Fellowship in HematoOncology, UUCM AMC
- Residency in Internal Medicine, UUCM AMC
- Internship in Seoul National University Hospital
Hospital
Asan Medical Centre, Seoul, South Korea
Specialization
- Hematopoietic Stem Cell Transplantation,
- Leukemia,
- Myelodysplastic Syndrome,
- Blood disease,
- Cell Therapy
Procedures Performed
- Stem cell transplant
- Cell therapies
- Immunotherapy
Research & Publications
| Prognostic impact of lymphocyte subpopulations in peripheral blood after hematopoietic stem cell transplantation for hematologic malignancies. |
| The detailed kinetics of cytomegalovirus-specific T cell responses after hematopoietic stem cell transplantation: 1 year follow-up data. |
| Allogeneic hematopoietic cell transplantation for lymphoma: baseline and posttransplant prognostic factors. |
| Benefits of hypomethylating therapy in IPSS lower-risk myelodysplastic syndrome patients: A retrospective multicenter case series study. |
| Clinical characteristics and outcomes of patients with chronic disseminated candidiasis who need adjuvant corticosteroid therapy. |
| Efficacy of eculizumab in paroxysmal nocturnal hemoglobinuria patients with or without aplastic anemia: prospective study of a Korean PNH cohort. |
| Epidemiology and Risk Factors for Invasive Fungal Diseases among Allogeneic Hematopoietic Stem Cell Transplant Recipients in Korea: Results of “RISK” Study. |
| Establishment and characterization of hypomethylating agent-resistant cell lines, MOLM/AZA-1 and MOLM/DEC-5. |
| Expression and prognostic significance of microRNAs in Korean patients with myelodysplastic syndrome. |
| Induction of immunoglobulin transcription factor 2 and resistance to MEK inhibitor in melanoma cells. |
